Why the study?
Does acute amino acid infusion (L-arginine, D-arginine, glycine) alter blood pressure and renal hemodynamics in rats with hypertension induced by chronic nitric oxide blockade?
Does acute amino acid infusion (L-arginine, D-arginine, glycine) alter blood pressure and renal hemodynamics in rats with hypertension induced by chronic nitric oxide blockade?
In a rat model of hypertension induced by chronic NO blockade, the kidney remains responsive to the vasodilatory effects of L-arginine despite a lack of systemic blood pressure reduction, suggesting hypertension maintenance is not solely due to competitive inhibition of NO production.
Should not change practice; hypothesis-generating for renal NO responsiveness in experimental hypertension.
L-Arginine is the physiological substrate of nitric oxide, a vasodilator that controls blood pressure and renal hemodynamics in the basal state. In the present studies, we produced chronic nitric oxide blockade by oral administration of the L-arginine analogue NG-nitro-L-arginine methyl ester, which produced sustained hypertension and increased renal vascular resistance in conscious rats. Acute excess L-arginine had little effect on blood pressure but completely normalized renal vascular resistance and increased renal plasma flow in chronically nitric oxide-blocked hypertensive rats. In contrast to L-arginine, D-arginine had no renal hemodynamic effects in either normal or chronically nitric oxide-blocked rats. Acutely administered glycine was ineffective in vasodilating the chronically nitric oxide-blocked rat kidney, in a dose that produced renal vasodilation in normal rats. These findings indicate the following: (1) Hypertension induced by chronic nitric oxide blockade due to substituted L-arginine analogue cannot be acutely reversed with excess L-arginine, suggesting that the maintenance of the hypertension is not solely caused by competitive inhibition of nitric oxide production; (2) in contrast, the kidney remains responsive to L-arginine whereas the renal vasodilator response to glycine is abolished in this model of hypertension.
No takes yet. Share an insight, caveat, or question.
Qiu et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: